COVID-19 presents enormous challenges to research ethics oversight. Here, we’ve begun a collection of oversight-related resources in order to best prepare our community for the operational and review concerns brought on by the viral outbreak. Read more
More than 100 research trials are reported to be underway on coronavirus already. It remains essential to lean on prior conversations and learning to put us in a position to conduct the best, most ethical research we can in a time of crisis. Read more
You are a member of an IRB reviewing a Phase 2 study for cardozamine, a new drug for treating stress. One of the exclusion criteria in the protocol is: “Educated or employed as an attorney.” The cover letter on the application explains that the study sponsor has been sued on three occasions by attorneys who were study subjects, and does not want it to happen again. You have no other information to make your decision and no clever way to dodge it. Read more
by Maeve Luthin, JD, Project Coordinator
It’s your favorite time of the week again! Take a few minutes to catch up with the research ethics world by reading through this edition of our Research Ethics Roundup.
US Regulator Plans to Declare Research Chimps Endangered: The US Fish and Wildlife Service Read more
by Megan Frame, Membership Coordinator
Today we’d like to introduce you to Susan “Sue” Fish, PharmD, MPH, who serves as chair of PRIM&R’s Membership Committee and as a member of the Diversity Advisory Group. She is also the secretary of PRIM&R’s Board of Directors and co-chairs the Poster Abstract Sub-Committee for the Read more
